Related Experiment Video

Updated: Jun 11, 2026

Real-Time Quantitative Measurement of Tumor Cell Migration and Invasion Following Synthetic mRNA Transfection
11:00

Real-Time Quantitative Measurement of Tumor Cell Migration and Invasion Following Synthetic mRNA Transfection

Published on: June 23, 2023

Regulation of Transgene Expression in Tumor Cells by Exploiting Endogenous Intracellular Signals

Daisuke Asai, Jeong-Hun Kang, Riki Toita

    Nanoscale Research Letters
    |July 2, 2010
    PubMed

    Insights

    This study introduces a novel gene therapy system that uses protein kinase C (PKC)alpha as a trigger for cell-specific transgene expression. The system demonstrates targeted gene delivery and expression in diseased cells, offering a promising approach for cancer therapy.

    Area of Science:

    • Biotechnology
    • Molecular Biology
    • Gene Therapy

    Background:

    • Cell-specific gene therapy requires precise control over transgene expression.
    • Intracellular signals abnormally activated in diseased cells can serve as triggers for targeted gene activation.

    Purpose of the Study:

    • To develop and validate a novel gene therapy system utilizing protein kinase C (PKC)alpha as a specific intracellular trigger.
    • To assess the efficacy and specificity of a PKCalpha-responsive polymer conjugate for gene delivery.

    Main Methods:

    • Preparation of a PKCalpha-responsive polymer conjugate [PPC(S)] and a non-responsive control [PPC(A)].
    • Phosphorylation assays using radiolabeled ATP to confirm conjugate response to PKCalpha.
    • Microinjection of polymer/DNA complexes into HepG2 cells to evaluate Green Fluorescent Protein (GFP) expression.
    • Inhibition studies using a PKCalpha inhibitor (Ro31-7549) to confirm pathway specificity.

    Main Results:

    • PPC(S)/DNA complexes showed significant phosphorylation in the presence of PKCalpha, unlike PPC(A)/DNA complexes.
    • Microinjection of PPC(S)/DNA complexes resulted in substantial GFP expression in HepG2 cells, while PPC(A)/DNA complexes showed no expression.
    • GFP expression mediated by PPC(S)/DNA complexes was effectively suppressed by a PKCalpha inhibitor, confirming pathway-dependent activation.

    Conclusions:

    • The developed gene regulation system demonstrates high specificity for PKCalpha activity.
    • This system holds potential for targeted transgene expression in tumor cells, paving the way for advanced cancer gene therapies.

    More Related Videos

    Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas09:21

    Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

    Published on: September 13, 2019

    Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells09:37

    Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

    Published on: August 25, 2021

    Related Concept Videos

    mTOR Signaling and Cancer Progression03:03

    mTOR Signaling and Cancer Progression

    The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
    The mTOR pathway or the...
    Tumor Immunotherapy01:27

    Tumor Immunotherapy

    Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
    Mitogens and the Cell Cycle02:38

    Mitogens and the Cell Cycle

    Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
    Reporter Genes02:11

    Reporter Genes

    Reporter genes are a type of protein-coding gene that are often tagged to a gene of interest. Once inside a target cell, reporter genes usually produce visually identifiable characteristics like fluorescence and luminescence when expressed along with the gene of interest. Thus, reporter genes “report” the presence or absence of genes of interest in an organism, determine the gene expression pattern, or track the physical location of a DNA segment or protein in the cell.
    Commonly used reporter...